• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,158
2,054
1,977
1,632
1,448

COUNTRY

1,008
796
248
217
175

CATEGORIES

  • 943
  • 190
  • 125
  • 327
    • 55
  • 471
  • 233
  • 264
  • 65
  • 79
  • 814
  • 1,445
  • 855
  • 24
  • 460
  • 1,370
  • 2,267
    • 89
    • 129
    • 72
    • 72
    • 43
    • 43
    • 21
    • 17
    • 20
    • 22
  • 25
  • 273
  • 49

PRICE

5,280
10,592
20,027
26,193

PUBLISHED

3,658
5,063
10,196
26,193

PRODUCT TYPE

22,083
1,956
1,009
893
164
37
21
19
6
4
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Merz Pharma GmbH & Co. KgaA - Product Pipeline Review - 2014

Merz Pharma GmbH & Co. KgaA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Merz Pharma GmbH & Co. KgaA - Product Pipeline Review - 2014’, provides an overview of the Merz Pharma...

April 2014
FROM

Metastatic Ovarian Cancer - Pipeline Review, H1 2014

Metastatic Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Ovarian Cancer’s...

April 2014
FROM

Fujifilm Corporation - Product Pipeline Review - 2014

Fujifilm Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Fujifilm Corporation - Product Pipeline Review - 2014’, provides an overview of the Fujifilm Corporation’s pharmaceutical...

April 2014
FROM

MI.TO. Technology S.r.L. - Product Pipeline Review - 2014

MI.TO. Technology S.r.L. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘MI.TO. Technology S.r.L. - Product Pipeline Review - 2014’, provides an overview of the MI.TO. Technology’s...

April 2014
FROM

Lung Adenocarcinoma - Pipeline Review, H1 2014

Lung Adenocarcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Lung Adenocarcinoma - Pipeline Review, H1 2014’, provides an overview of the Lung Adenocarcinoma’s therapeutic pipeline. This...

April 2014
FROM

Spasticity - Pipeline Review, H1 2014

Spasticity - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Spasticity - Pipeline Review, H1 2014’, provides an overview of the Spasticity’s therapeutic pipeline. This report provides...

April 2014
FROM

Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2014

Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Streptococcus Pneumoniae Infection - Pipeline Review, H1 2014’, provides an overview...

April 2014
FROM

Sepsis - Pipeline Review, H1 2014

Sepsis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2014’, provides an overview of the Sepsis’s therapeutic pipeline. This report provides comprehensive...

April 2014
FROM

Myelofibrosis - Pipeline Review, H1 2014

Myelofibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myelofibrosis - Pipeline Review, H1 2014’, provides an overview of the Myelofibrosis’s therapeutic pipeline. This report...

April 2014
FROM

Rabies - Pipeline Review, H1 2014

Rabies - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rabies - Pipeline Review, H1 2014’, provides an overview of the Rabies’s therapeutic pipeline. This report provides comprehensive...

April 2014
FROM

Curis, Inc. - Product Pipeline Review - 2014

Curis, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Curis, Inc. - Product Pipeline Review - 2014’, provides an overview of the Curis, Inc.’s pharmaceutical research and...

April 2014
FROM

Curaxys, S.L. - Product Pipeline Review - 2014

Curaxys, S.L. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Curaxys, S.L. - Product Pipeline Review - 2014’, provides an overview of the Curaxys, S.L.’s pharmaceutical research...

April 2014
FROM

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014’, provides an overview of...

April 2014
FROM

Friedreich Ataxia - Pipeline Review, H1 2014

Friedreich Ataxia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Friedreich Ataxia - Pipeline Review, H1 2014’, provides an overview of the Friedreich Ataxia’s therapeutic pipeline. This...

April 2014
FROM

Genital Herpes - Pipeline Review, H1 2014

Genital Herpes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H1 2014’, provides an overview of the Genital Herpes’s therapeutic pipeline. This report...

April 2014
FROM

Arrhythmias - Pipeline Review, H1 2014

Arrhythmias - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Arrhythmias - Pipeline Review, H1 2014’, provides an overview of the Arrhythmias’s therapeutic pipeline. This report provides...

April 2014
FROM

Genor BioPharma Co., Ltd. - Product Pipeline Review - 2014

Genor BioPharma Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Genor BioPharma Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the Genor BioPharma...

April 2014
FROM

Selvita S.A - Product Pipeline Review - 2014

Selvita S.A - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Selvita S.A - Product Pipeline Review - 2014’, provides an overview of the Selvita S.A’s pharmaceutical research and...

April 2014
FROM

Insomnia - Pipeline Review, H1 2014

Insomnia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2014’, provides an overview of the Insomnia’s therapeutic pipeline. This report provides comprehensive...

April 2014
FROM

Choroidal Neovascularization - Pipeline Review, H1 2014

Choroidal Neovascularization - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Choroidal Neovascularization - Pipeline Review, H1 2014’, provides an overview of the Choroidal Neovascularization’s...

April 2014
FROM
Loading Indicator

Our Clients

Our clients' logos